ATE401885T1 - Nikotinhaltige zusammensetzung mit gesteuerter freisetzung und verfahren - Google Patents

Nikotinhaltige zusammensetzung mit gesteuerter freisetzung und verfahren

Info

Publication number
ATE401885T1
ATE401885T1 AT03724037T AT03724037T ATE401885T1 AT E401885 T1 ATE401885 T1 AT E401885T1 AT 03724037 T AT03724037 T AT 03724037T AT 03724037 T AT03724037 T AT 03724037T AT E401885 T1 ATE401885 T1 AT E401885T1
Authority
AT
Austria
Prior art keywords
nicotine
aqueous solution
functional groups
product
cation exchange
Prior art date
Application number
AT03724037T
Other languages
English (en)
Inventor
John Walling
Original Assignee
Cambrex Charles City Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22602397&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE401885(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Cambrex Charles City Inc filed Critical Cambrex Charles City Inc
Application granted granted Critical
Publication of ATE401885T1 publication Critical patent/ATE401885T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/465—Nicotine; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Addiction (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AT03724037T 2002-05-28 2003-04-15 Nikotinhaltige zusammensetzung mit gesteuerter freisetzung und verfahren ATE401885T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10/166,236 US6586449B1 (en) 2002-05-28 2002-05-28 Nicotine-containing, controlled release composition and method

Publications (1)

Publication Number Publication Date
ATE401885T1 true ATE401885T1 (de) 2008-08-15

Family

ID=22602397

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03724037T ATE401885T1 (de) 2002-05-28 2003-04-15 Nikotinhaltige zusammensetzung mit gesteuerter freisetzung und verfahren

Country Status (10)

Country Link
US (2) US6586449B1 (de)
EP (1) EP1549633B1 (de)
AT (1) ATE401885T1 (de)
CY (1) CY1108411T1 (de)
DE (2) DE03724037T1 (de)
DK (1) DK1549633T3 (de)
ES (1) ES2285969T3 (de)
PT (1) PT1549633E (de)
SI (1) SI1549633T1 (de)
WO (1) WO2003101982A1 (de)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7198801B2 (en) 2000-08-03 2007-04-03 Antares Pharma Ipl Ag Formulations for transdermal or transmucosal application
US8980290B2 (en) 2000-08-03 2015-03-17 Antares Pharma Ipl Ag Transdermal compositions for anticholinergic agents
ATE485837T1 (de) * 2000-08-03 2010-11-15 Antares Pharma Ipl Ag Zusammensetzung zur transdermalen und/oder transmukosalen verabreichung von wirkstoffen, die ausreichende therapeutische spiegel garantiert
SE521512C2 (sv) 2001-06-25 2003-11-11 Niconovum Ab Anordning för administrering av en substans till främre delen av en individs munhåla
PT1578422E (pt) * 2002-12-20 2007-06-14 Niconovum Ab Material particulado contendo nicotina fisicamente e quimicamente estável
ATE534373T1 (de) 2003-10-10 2011-12-15 Antares Pharma Ipl Ag Transdermale pharmazeutische formulierung zur minimierung von rückständen auf der haut
US7387788B1 (en) 2003-10-10 2008-06-17 Antares Pharma Ipl Ag Pharmaceutical compositions of nicotine and methods of use thereof
WO2005053691A2 (en) * 2003-12-02 2005-06-16 Fertin Pharma A/S Nicotine delivery product and method for producing it
US7425340B2 (en) 2004-05-07 2008-09-16 Antares Pharma Ipl Ag Permeation enhancing compositions for anticholinergic agents
US8067399B2 (en) 2005-05-27 2011-11-29 Antares Pharma Ipl Ag Method and apparatus for transdermal or transmucosal application of testosterone
WO2006128468A1 (en) * 2005-06-01 2006-12-07 Fertin Pharma A/S A method of manufacturing a nicotine delivery product
KR100699582B1 (ko) 2005-07-11 2007-03-23 삼성전기주식회사 출력 버퍼회로
AU2007224584A1 (en) 2006-03-16 2007-09-20 Niconovum Ab Improved snuff composition
CN101426475A (zh) 2006-04-21 2009-05-06 安塔雷斯制药Ipl股份公司 使用用于经皮或经粘膜应用的制剂治疗热潮红的方法
US20070286903A1 (en) * 2006-06-13 2007-12-13 Becicka Brian T Composition and method for taste masking
US8642016B2 (en) * 2006-07-21 2014-02-04 Jsrnti, Llc Medicinal delivery system, and related methods
US9125434B2 (en) 2007-10-11 2015-09-08 Philip Morris Products S.A. Smokeless tobacco product, smokeless tobacco product in the form of a sheet, extrudable tobacco composition, method for manufacturing a smokeless tobacco product, method for delivering super bioavailable nicotine contained in tobacco to a user, and packaged smokeless tobacco product sheet
WO2009048522A1 (en) * 2007-10-11 2009-04-16 Richard Fuisz Smokeless tobacco product
DK2198865T3 (da) 2008-12-19 2012-01-16 Siegfried Ltd Nikotinholdigt produkt
US8728444B2 (en) 2010-05-31 2014-05-20 Fertin Pharma A/S Formulation comprising nicotine and a cation exchange resin
WO2011150959A1 (en) * 2010-05-31 2011-12-08 Fertin Pharma A/S Formulation comprising nicotine and a cation exchange resin
US9084439B2 (en) 2011-09-22 2015-07-21 R.J. Reynolds Tobacco Company Translucent smokeless tobacco product
US9629392B2 (en) 2011-09-22 2017-04-25 R.J. Reynolds Tobacco Company Translucent smokeless tobacco product
US9474303B2 (en) 2011-09-22 2016-10-25 R.J. Reynolds Tobacco Company Translucent smokeless tobacco product
US20130078307A1 (en) 2011-09-22 2013-03-28 Niconovum Usa, Inc. Nicotine-containing pharmaceutical composition
US9763928B2 (en) 2012-02-10 2017-09-19 Niconovum Usa, Inc. Multi-layer nicotine-containing pharmaceutical composition
US9044035B2 (en) 2012-04-17 2015-06-02 R.J. Reynolds Tobacco Company Remelted ingestible products
ES2814296T3 (es) 2016-04-21 2021-03-26 Fertin Pharma As Producto para administración de nicotina, usos relacionados y formas de dosificación oral y métodos de producción
US20220151292A1 (en) * 2020-11-16 2022-05-19 Ncp Nextgen A/S Nicotine pouch composition

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3901248A (en) * 1970-07-22 1975-08-26 Leo Ab Chewable smoking substitute composition
US3845217A (en) * 1972-11-16 1974-10-29 Helsingborg L Ab Buffered smoking substitute compositions
US4692462A (en) * 1985-03-18 1987-09-08 Menley & James Laboratories, Ltd. Compositions and method of controlling transdermal penetration of topical and systemic agents
AU5354994A (en) * 1992-10-15 1994-05-09 Alza Corporation Delayed onset transdermal delivery device
GB9310412D0 (en) * 1993-05-20 1993-07-07 Danbiosyst Uk Nasal nicotine system

Also Published As

Publication number Publication date
SI1549633T1 (sl) 2009-02-28
EP1549633A1 (de) 2005-07-06
EP1549633A4 (de) 2007-04-04
US6586449B1 (en) 2003-07-01
ES2285969T3 (es) 2008-12-16
CY1108411T1 (el) 2014-02-12
DK1549633T3 (da) 2008-10-06
US6828336B2 (en) 2004-12-07
ES2285969T1 (es) 2007-12-01
EP1549633B1 (de) 2008-07-23
WO2003101982A1 (en) 2003-12-11
US20030224048A1 (en) 2003-12-04
DE60322405D1 (de) 2008-09-04
DE03724037T1 (de) 2007-10-11
PT1549633E (pt) 2008-10-02

Similar Documents

Publication Publication Date Title
CY1108411T1 (el) Συνθεση περιεχουσα νικοτινη ελεγχομενης απελευθερωσης και μεθοδος
ATE410400T1 (de) Verfahren zur herstellung von c13- alkoholgemischen
ES8302770A1 (es) Un metodo de retardar o impedir la gelificacion de una sus- pension de materia prima para detergente
ATE286965T1 (de) Verfahren zur herstellung fester reinigungsmittel-komponenten
ATE501243T1 (de) Verfahren zur sprühtrocknung zur herstellung von sprühgetrocknete stark wasserlösliche waschmittel mit geringer dichte und niedrigem buildergehalt.
DE50110261D1 (de) Verfahren zur herstellung von nichtionischen tensidgranulaten
DK1696923T3 (da) Nikotinafgivelsesprodukt og fremgangsmåde til fremstilling deraf
ATE533731T1 (de) Verfahren zur herstellung einer fällungskieselsäure mit niedriger wasseraufnahme
ATE22462T1 (de) Verfahren zur herstellung von stueckseifen mit hohem glyceringehalt.
JP2005534778A5 (de)
ATE448786T1 (de) Verfahren zur herstellung eines nikotinzuführenden produkts
ATE64317T1 (de) Verfahren zur herstellung von zusammensetzungen mit granularer form, welche chemische stoffe fuer die landwirtschaft enthalten.
CN109499382A (zh) 一种反渗透膜用清洗组合物及其制备方法
EP1525044B8 (de) Verfahren zur reinigung von luft, vorrichtung zur reinigung von luft und mit dieser vorrichtung versehenes gebäude
ATE258779T1 (de) Verfahren zur herstellung einer nagellackzusammensetzung
CN102533478A (zh) 一种含钙难溶固体的复配溶解清洗剂及其制造方法
US1296468A (en) Toxic cement.
JPS51116197A (en) Method for production of removing agent for phosphate in solution
DE3144298C2 (de)
CN103738927A (zh) 一种快速溶解型颗粒过碳酸钠的制备工艺
KR102628785B1 (ko) 구연산폐액을 이용한 재생석고 제조 방법 및 그 방법에의해 제조된 재생석고
DE602004001206D1 (de) Verfahren zur Herstellung einer Substanz zur Behandlung von Oberflächen
ATE1911T1 (de) Verfahren zur herstellung eines schaumgedaempften waschmittels.
SU1074897A1 (ru) Моющее средство "РМК-АК-1" дл очистки молочного оборудовани и способ его получени
CN100409941C (zh) 乙二醇苯醚生产工艺中用的催化剂

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1549633

Country of ref document: EP